Covered recipient · General Payments record
DIEM CHIEU CHANG
Dental Providers Dentist General Practice
General Payments · PY2018–2024
$5,505.04
- Reported across 152 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $891.35 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $631.71 | 5 |
| Embecta Corp. | $134.14 | 7 |
| DEXCOM, INC. | $75.34 | 4 |
| Novo Nordisk AS | $50.16 | 3 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $124.51 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111545865 | CMS |
| Amgen Inc. | $120.40 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111545867 | CMS |
| Amgen Inc. | $120.80 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111545869 | CMS |
| Amgen Inc. | $146.24 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111545871 | CMS |
| Amgen Inc. | $119.76 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111545873 | CMS |
| Dexcom, Inc. | $20.13 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153296572 | CMS |
| Dexcom, Inc. | $20.28 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153296570 | CMS |
| Dexcom, Inc. | $18.08 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153296574 | CMS |
| Dexcom, Inc. | $16.85 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153296576 | CMS |
| Embecta Corp. | $16.27 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144992381 | CMS |
| Embecta Corp. | $18.76 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144992305 | CMS |
| Embecta Corp. | $20.44 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144992353 | CMS |
| Embecta Corp. | $22.48 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144992481 | CMS |
| Embecta Corp. | $18.73 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144992433 | CMS |
| Embecta Corp. | $18.73 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144992491 | CMS |
| Embecta Corp. | $18.73 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144992509 | CMS |
| Novo Nordisk Inc | $19.64 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096745870 | CMS |
| Novo Nordisk Inc | $13.46 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096663939 | CMS |
| Novo Nordisk Inc | $17.06 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096925884 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.